Cargando…
Cystathionine β-Synthase Inhibition Is a Potential Therapeutic Approach to Treatment of Ischemic Injury
Hydrogen sulfide (H(2)S) has been reported to exacerbate stroke outcome in experimental models. Cystathionine β-synthase (CBS) has been implicated as the predominant H(2)S-producing enzyme in central nervous system. When SH-SY5Y cells were transfected to overexpress CBS, these cells were able to syn...
Autores principales: | Chan, Su Jing, Chai, Chou, Lim, Tze Wei, Yamamoto, Mie, Lo, Eng H, Lai, Mitchell Kim Peng, Wong, Peter Tsun Hon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4397212/ https://www.ncbi.nlm.nih.gov/pubmed/25873304 http://dx.doi.org/10.1177/1759091415578711 |
Ejemplares similares
-
Cystathionine β-Synthase in Physiology and Cancer
por: Zhu, Haoran, et al.
Publicado: (2018) -
Serum Proteome Alterations in Human Cystathionine β-Synthase Deficiency and Ischemic Stroke Subtypes
por: Sikora, Marta, et al.
Publicado: (2019) -
Cystathionine β-Synthase Is Necessary for Axis Development in Vivo
por: Prabhudesai, Shubhangi, et al.
Publicado: (2018) -
Association of Cystathionine β-Synthase Gene Polymorphisms With
Preeclampsia
por: de León Bautista, Mercedes Piedad, et al.
Publicado: (2018) -
Cystathionine-β-synthase: Molecular Regulation and Pharmacological Inhibition
por: Zuhra, Karim, et al.
Publicado: (2020)